Volume 13, Issue 4 (July 2011) 13, 614–615; 10.1038/aja.2011.38

Prostate-specific antigen (PSA) velocity: a test of controversial benefit in the era of increased prostate cancer screening

Michael S Borofsky¹ and Danil V Makarov²

1 Department of Urology, New York University School of Medicine, New York, NY 10016, USA
2 Department of Urology and The Section on Value and Comparative Effectiveness, New York University School of Medicine, New York, NY 10016, USA

Correspondence: Dr MS Borofsky, (Michael.Borofsky@nyumc.org)